
### [MONDO:0020089](http://purl.obolibrary.org/obo/MONDO_0020089)
**Label:** acquired lipodystrophy

**Subclasses:** [MONDO:0019555](http://purl.obolibrary.org/obo/MONDO_0019555) (panniculitis and localized lipodystrophy), [MONDO:0019556](http://purl.obolibrary.org/obo/MONDO_0019556) (pressure-induced localized lipoatrophy), [MONDO:0019553](http://purl.obolibrary.org/obo/MONDO_0019553) (drug-induced localized lipodystrophy), [MONDO:0019554](http://purl.obolibrary.org/obo/MONDO_0019554) (idiopathic localized lipodystrophy), [MONDO:0019552](http://purl.obolibrary.org/obo/MONDO_0019552) (Centrifugal lipodystrophy), [MONDO:0012104](http://purl.obolibrary.org/obo/MONDO_0012104) (partial acquired lipodystrophy), [MONDO:0019193](http://purl.obolibrary.org/obo/MONDO_0019193) (acquired generalized lipodystrophy), [MONDO:0019194](http://purl.obolibrary.org/obo/MONDO_0019194) (localized lipodystrophy), 

**Corr. equiv. classes:** [Orphanet:90157](http://www.orpha.net/ORDO/Orphanet_90157), [Orphanet:90158](http://www.orpha.net/ORDO/Orphanet_90158), [Orphanet:90159](http://www.orpha.net/ORDO/Orphanet_90159), [Orphanet:79086](http://www.orpha.net/ORDO/Orphanet_79086), [Orphanet:90160](http://www.orpha.net/ORDO/Orphanet_90160), [Orphanet:79087](http://www.orpha.net/ORDO/Orphanet_79087), [Orphanet:79088](http://www.orpha.net/ORDO/Orphanet_79088), [OMIM:608709](http://purl.obolibrary.org/obo/OMIM_608709), [Orphanet:90156](http://www.orpha.net/ORDO/Orphanet_90156), 

**Class expressions from DL-Learner:**

- [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) 77.78%
- [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) and [HP:0100578](http://purl.obolibrary.org/obo/HP_0100578) (Lipoatrophy) 77.78%
- [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) 77.78%
- [HP:0003758](http://purl.obolibrary.org/obo/HP_0003758) (Reduced subcutaneous adipose tissue) and [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) 77.78%
- [HP:0001001](http://purl.obolibrary.org/obo/HP_0001001) (Abnormality of subcutaneous fat tissue) and [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) 77.78%
- [HP:0003758](http://purl.obolibrary.org/obo/HP_0003758) (Reduced subcutaneous adipose tissue) and [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) and [HP:0100578](http://purl.obolibrary.org/obo/HP_0100578) (Lipoatrophy) 77.78%
- [HP:0001001](http://purl.obolibrary.org/obo/HP_0001001) (Abnormality of subcutaneous fat tissue) and [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0010783](http://purl.obolibrary.org/obo/HP_0010783) (Erythema) and [HP:0100578](http://purl.obolibrary.org/obo/HP_0100578) (Lipoatrophy) 77.78%
- [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0100578](http://purl.obolibrary.org/obo/HP_0100578) (Lipoatrophy) 73.42%
- [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 73.42%
- [HP:0003758](http://purl.obolibrary.org/obo/HP_0003758) (Reduced subcutaneous adipose tissue) and [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) 73.42%
- [HP:0001001](http://purl.obolibrary.org/obo/HP_0001001) (Abnormality of subcutaneous fat tissue) and [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) 73.42%
- [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0100578](http://purl.obolibrary.org/obo/HP_0100578) (Lipoatrophy) 73.42%
- [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) and [HP:0100578](http://purl.obolibrary.org/obo/HP_0100578) (Lipoatrophy) 73.42%
- [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0100578](http://purl.obolibrary.org/obo/HP_0100578) (Lipoatrophy) 73.42%
- [HP:0007485](http://purl.obolibrary.org/obo/HP_0007485) (Absence of subcutaneous fat) and [HP:0009125](http://purl.obolibrary.org/obo/HP_0009125) (Lipodystrophy) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 73.42%


